In vitro activity of midecamycin, a new macrolide antibiotic.

Antimicrobial agents and chemotherapy ·Vol. 24 ·No. 3 ·1983-09-00 ·Pages 443-4

Neu HC

Abstract

Midecamycin, an acetoxy-substituted macrolide antibiotic, was tested against gram-positive and gram-negative bacteria. It inhibited the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 micrograms/ml. It was less active than erythromycin, and it failed to inhibit erythromycin-resistant isolates.

MeSH Terms

Anti-Bacterial Agents/pharmacology Bacteria/drug effects Leucomycins/pharmacology Microbial Sensitivity Tests

Chemicals

Anti-Bacterial Agents Leucomycins midecamycin

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Neu H C

Article Info

Journal

Antimicrobial agents and chemotherapy

Abbr.

Antimicrob Agents Chemother

ISSN

0066-4804

DOI

10.1128/AAC.24.3.443

Published

1983-09-00

Pages

443-4

Language

English

Region

United States

NLM ID

0315061

PMCID

PMC185343

Subset

External Links

PubMed source DOI: 10.1128/AAC.24.3.443 PMC Full Text View journal details

Analysis Services

In vitro activity of midecamycin, a new macrolide antibiotic.

Contact

WeChat Official Account